Biomimetic Glucose Trigger‐Insulin Release System Based on Hydrogel Loading Bidentate β‐Cyclodextrin
Renqi Wang,Yuhui Tian,Jiankang Wang,Wenxuan Song,Yong Cong,Xuebing Wei,Yingwu Mei,Hideyuki Miyatake,Yoshihiro Ito,Yong Mei Chen
DOI: https://doi.org/10.1002/adfm.202104488
IF: 19
2021-07-03
Advanced Functional Materials
Abstract:<p>Initiated by the specific binding between D-glucose and biological receptors, the human body has a delicate metabolic system to regulate blood D-glucose levels, but failing to release insulin would induce hyperglycemia or type I diabetes. While insulin delivery is an effective form of hyperglycemia therapy, the self-regulated triggering of insulin release for on-demand supplementation remains inadequate. Here, a biomimetic glucose trigger-insulin release system, that is, a bidentate β-cyclodextrin-based hydrogel with preloaded insulin is presented; the dual self-regulated system shows a specific D-glucose response to realize accurate monitoring and simultaneous on-demand trigger insulin release. The specific binding between D-glucose and the bidentate β-cyclodextrin induces the release of protons, causing macroscopic swelling of the hydrogel, subsequently triggering the on-demand and long-term supplementation of insulin. On the contrary, isomers of D-glucose, such as D-fructose and D-galactose, cause shrinking of the hydrogel, and retard insulin release. In-vivo studies in type I diabetic mice model ascertain that although the bidentate β-CD hydrogel is preloaded with short-activity insulin, it exerts long-activity control of blood glucose level over 12 h.</p>
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology